These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20693825)

  • 1. Influence of visceral obesity on oncologic outcome in patients with renal cell carcinoma.
    Naya Y; Zenbutsu S; Araki K; Nakamura K; Kobayashi M; Kamijima S; Imamoto T; Nihei N; Suzuki H; Ichikawa T; Igarashi T
    Urol Int; 2010; 85(1):30-6. PubMed ID: 20693825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral obesity in predicting oncologic outcomes of localized renal cell carcinoma.
    Park YH; Lee JK; Kim KM; Kook HR; Lee H; Kim KB; Lee S; Byun SS; Lee SE
    J Urol; 2014 Oct; 192(4):1043-9. PubMed ID: 24704011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma.
    Bertini R; Roscigno M; Freschi M; Strada E; Angiolilli D; Petralia G; Matloob R; Sozzi F; Capitanio U; Da Pozzo LF; Colombo R; Guazzoni G; Cremonini A; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):358-65. PubMed ID: 21640483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of tumor volume on survival in patients with renal cell carcinoma.
    Seçil M; Çullu N; Aslan G; Mungan U; Uysal F; Tuna B; Yörükoğlu K
    Diagn Interv Radiol; 2012; 18(5):480-7. PubMed ID: 22618630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated visceral obesity quantified by CT is associated with adverse postoperative outcome of laparoscopic radical nephrectomy for renal clear cell carcinoma patients.
    Zhai T; Zhang B; Qu Z; Chen C
    Int Urol Nephrol; 2018 May; 50(5):845-850. PubMed ID: 29611145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between visceral obesity and the clinicopathologic features of patients with small renal masses.
    Keehn A; Srivastava A; Maiman R; Taylor J; DiVito J; Ghavamian R; Stern JM
    J Endourol; 2015 Mar; 29(3):372-6. PubMed ID: 25203393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal cell carcinoma of the native kidney: a frequent tumor after kidney transplantation with favorable prognosis in case of early diagnosis.
    Végsö G; Toronyi E; Hajdu M; Piros L; Görög D; Deák PA; Doros A; Péter A; Langer RM
    Transplant Proc; 2011 May; 43(4):1261-3. PubMed ID: 21620106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathological prognostic indicators in renal cell carcinoma].
    Rey Rey J; León Ramírez D; López García S; Fernández Vázquez P; Benavente Delgado J; Ojea Calvo A
    Actas Urol Esp; 2010 Jan; 34(1):71-7. PubMed ID: 20223135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors.
    Kamat AM; Shock RP; Naya Y; Rosser CJ; Slaton JW; Pisters LL
    Urology; 2004 Jan; 63(1):46-50. PubMed ID: 14751346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real indications for adrenalectomy in renal cell carcinoma.
    Moudouni SM; En-Nia I; Patard JJ; Manunta A; Guillé F; Lobel B
    Scand J Urol Nephrol; 2002; 36(4):273-7. PubMed ID: 12201919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.
    Weight CJ; Kim SP; Lohse CM; Cheville JC; Thompson RH; Boorjian SA; Leibovich BC
    Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of visceral obesity in patients with advanced renal cell carcinoma undergoing nephrectomy.
    Lee HW; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
    Int J Urol; 2015 May; 22(5):455-61. PubMed ID: 25631365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lymph node invasion and sarcomatoid differentiation on the survival of patients with locally advanced renal cell carcinoma.
    Rodríguez-Covarrubias F; Castillejos-Molina R; Sotomayor M; Méndez-Probst CE; Gómez-Alvarado MO; Uribe-Uribe N; Gabilondo F; Feria-Bernal G
    Urol Int; 2010; 85(1):23-9. PubMed ID: 20693824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of visceral and subcutaneous adiposity with renal function in people with type 2 diabetes mellitus.
    Kim SR; Yoo JH; Song HC; Lee SS; Yoo SJ; Kim YD; Lim YS; Kim HW; Yang CW; Kim YS; Choi EJ; Kim YK
    Nephrol Dial Transplant; 2011 Nov; 26(11):3550-5. PubMed ID: 21030458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
    Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
    Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma.
    Rogde AJ; Gudbrandsdottir G; Hjelle KM; Sand KE; Bostad L; Beisland C
    Scand J Urol Nephrol; 2012 Oct; 46(5):348-57. PubMed ID: 22530756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.